GenVec
GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent...
www.genvec.com/ View full profile
| |
BioVex
BioVex is a three year old private biotech company that is developing a new class of potent vaccines principally to treat and prevent cancer. The Company is headquartered in Oxford, UK.
www.biovex.com./ View full profile
| |
BSD Medical
BSD Medical Corporation (AMEX: BSM) develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and...
www.bsdmc.com/ View full profile
| |
Delcath Systems
Our objective is to establish the use of the Delcath system as the standard technique for delivering chemotherapy agents to the liver and to expand the Delcath technology so that it may be used in the...
www.delcath.com/ View full profile
| |
Genetronics Biomedical
Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk,...
www.genetronics.com/ View full profile
| |
Hemispherx Biopharma
Hemispherx Biopharma, Inc. has devoted nearly three decades to exploring, understanding, and mastering the mechanism of RNA technology. The Company's longevity as a biomedical research and drug...
www.hemispherx.net/ View full profile
| |
KuDOS Pharmaceuticals Limited
KuDOS Pharmaceuticals is a leader in the discovery and development of novel small molecule drugs that target DNA repair and related systems for the treatment f human diseases, in particular cancer. ...
www.kudospharma.co.uk/ View full profile
| |
Lorus Therapeutics
Lorus Therapeutics Inc. is a pharmaceutical company focused on the development of cancer therapies. Lorus' goal is to capitalize on its pre-clinical, clinical and regulatory expertise by developing...
www.lorusthera.com/ View full profile
| |
Oxxon Pharmaccines Limited
Oxxon Pharmaccines™ Ltd is a biotechnology company developing novel pharmaccines (therapeutic vaccines) based on its unique PrimeBoost technologies for the treatment of chronic infectious diseases and...
www.oxxonpharmaccines.com/ View full profile
| |
Progen Pharmaceuticals
Progen Pharmaceuticals Limited (NASDAQ:PGLA; ASX: PGL) is a globally focused biotechnology company committed to improving patient outcomes through discovery and development of small molecule-based...
www.progen.com.au/ View full profile
| |
AmpliMed Corporation
AmpliMed Corporation develops novel drugs for the treatment of cancer. Our lead product, Amplimexon™ (imexon inj.), has particular promise for the treatment of pancreatic cancer, malignant melanoma,...
www.amplimed.com/ View full profile
| |
Dr.Stephan Ariyan
Dr. Stephan Ariyan is a Clinical Professor of Surgery, Plastic Surgery, and Otolaryngology at Yale University School of Medicine and Director, Yale Cancer Center Melanoma Unit. He was Professor and...
www.ariyan.com/ View full profile
| |
BioVex
BioVex is a biotechnology company focused on the development of novel biologics for the treatment of cancer. The Company’s platforms are based on the manipulation of the herpes simplex virus (HSV)....
www.biovex.com/ View full profile
| |
Electro-Optical Sciences
We are a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. Our flagship product, MelaFind, features...
www.eo-sciences.com/ View full profile
| |
GALDERMA LABORATORIES L.P.
Since the creation of Galderma in 1981 as a joint venture between Nestlé and L'Oréal, all of our resources have been channelled in one direction: to provide innovative therapeutic solutions that meet...
www.galderma.com/ View full profile
| |
